Clinical trial
Atrial Fibrillation After Resection (AFAR): A PROGRESS III Study
NCT04037319 is registered in ClinicalTrials.gov with Sheffield Teaching Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrial Fibrillation After Resection (AFAR): A PROGRESS III Study
- Lead sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 16, 2020
- Completion date
- March 31, 2024
- Enrollment
- 720 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation new onset, colorectal cancer